Trial Profile
A placebo-controlled study of three doses of aripiprazole in patients with acute schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Nov 2006
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 16 Nov 2006 Status change
- 09 Oct 2005 New trial record.